Faculty Information - Atsushi Nagai

Current specialization

Publications

Journal Articles

Presentations

（Last updated : 2025-08-12 17:43:04）

Atsushi Nagai
Department Kawasaki Medical School Faculty of Medicine, Kawasaki Medical School,

Position

■ Current specialization

Urology

■ Publications

1.	2013		Male Lower Urinary Tract Symptoms and Sexual Dysfunction, Male Lower Urinary Tract Symptoms(LUTS)
2.	2004/01		Retroperitoneoscopic pyelotomy, New Challenges in Laparoscopic Urologic Surgery (Recent Advances in Endourology 5 )

■ Journal Articles

1.	2019/03	Intra-abdominal desmoid tumor mimicking local recurrence of renal cell carcinoma after laparoscopic partial nephrectomy.
2.	2019/02	Multidimensional analysis of clinicopathological characteristics of false-negative clinically significant prostate cancers on multiparametric MRI of the prostate in Japanese men.
3.	2018	Male squirting: Analysis of one case using color Doppler ultrasonography
4.	2017/08	Long-term compliance and treatment failure of alpha1-blocker for patients with benign prostatic hyperplasia
5.	2016/11	Tadalafil for male lower urinary tract symptoms improves endothelial function
6.	2015/06	Practical application of color Doppler ultrasonography in patients with ejaculatory dysfunction
7.	2013/12	Testosterone replacement elevates the serum uric acid levels in patients with female to male gender identity disorder.
8.	2013/06	Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma
9.	2013/02	Long-term safety and efficacy of two different antimuscarinics, imidafenacin and solifenacin, for treatment of overactive bladder: a prospective randomized controlled study.
10.	2012/12	Lidocaine bladder instillation for prevention of autonomic dysreflexia during suprapubic cystostomy placement for upper spinal cord lesion
11.	2012/08	Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia: Preliminary Results with a Newly Purified Neurotoxin.
12.	2012/06	Application of Purified Botulinum Type A Neurotoxin to Treat Experimental Trigeminal Neuropathy in Rats and Patients with Urinary Incontinence and Prostatic Hyperplasia
13.	2012/05	Editorial Comment to Status of sex reassignment surgery for gender identity disorder in Japan
14.	2012/03	Botulinum toxin type A for the treatment of lower urinary tract disorders
15.	2012/03	Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results.
16.	2012/01	Comparison of two different alpha1-adrenoceptor antagonists, tamsulosin hydrochloride and silodosin, in the treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A prospective randomized crossover study.
17.	2011/11	Outline of JUA clinical guidelines for benign prostatic hyperplasia.
18.	2011/06	Retroperitoneoscopic Nephrectomy for Treatment of a Case of Left Single Ectopic Ureter Accompanied by Dysplastic Kidney
19.	2011/03	Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia
20.	2010/04	SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer.
21.	2009/10	Does transection of the spermatic cord lower the incidence of inguinal hernia after radical retropubic prostatectomy?
22.	2009/10	The Effects of 3 Types of Alpha1-Adrenoceptor Blockers on Lower Urinary Tract Symptoms and Sexual Functions in Men with Benign Prostatic Hyperplasia
23.	2009/09	Effects of Purified Newly Developed Botulinum Neutoxin Type A in Rat Prostate
24.	2009/04	Is primary hormone therapy efficient for clinically localized prostate cancer in Japanese men?
25.	2009/04	Naftopidil and Propiverin Hydrochrolide for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: A prospective randomized controlled study
26.	2009/04	Naftopidil and propiverin hydrochrolide for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: A prospective randomized controlled study.
27.	2009/04	The effect of purified newly developed Botulinum neurotoxin type A in rat and human prostate
28.	2008/10	Ejaculatory dysfunction caused by new A1-blocker:analysis of human ejaculatory phenomenon using color doppler ultrasonigraphy
29.	2008/06	A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy.
30.	2008/06	Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder
31.	2008/02	Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy.
32.	2007/12	The experience of using dual lumen ureteral access sheath (AquaGuide TM)in ureteropyeloscopy
33.	2007/08	Implication of amphiphysin 1 and dynamin 2 in tubulobulbar complex formation and spermatid release.
34.	2007/07	Natural course of lower urinary tract syptoms following discontinuation of alpha-1-adrenergic blockers in patients with benign prostatic hyperplasia.
35.	2007/03	Comparative study of oncologic outcome of laparoscopic nephroureterectomy and　standard nephroureterectomy for upper urinary tract transitional cell　carcinoma.
36.	2006/04	Penile reconstruction with bilateral superficial circumflex iliac artery perforator（SCIP）flaps.
37.	2006/02	Hepsin shows inhibitory effects through apoptotic pathway on ovarian cancer cell lines
38.	2005/12	Intracavernous injection of prostaglandin E1 is effective in patients with erectile dysfunction not responding to phosphodiseterase 5 inhibitors.
39.	2005/10	Minimal invasiveness and effectivity of subinguinal microscopic varicocelectomy:A comparative study with retroperitoneal high and laparoscopic approaches
40.	2005/10	Sex reassignment surgery for male to female transsexuals:Initial experience at Okayama University Hospital
41.	2005/07	Adeno-Associated Virus 2-Mediated intratumoral prostate cancer gene therapy:Long-term maspin expression efficiently suppresses tumor growth
42.	2005/07	Adeno-associated virus-mediated human IL-10 gene transfer suppresses the development of experimental autoimmune orchiti
43.	2005/07	Retroperitoneoscopic pyelolithotomy as initial treatment for upper urinary tract large stone
44.	2005/07	Varicocele rupture due to sexual intercourse
45.	2005/04	Clinical results of one-stage urethroplasty with parameatal foreskin flap for hypospadias
46.	2005/02	Analysis of human ejaculation using color doppler ultrasonography:A comparison between antegrade and retrograde ejaculation
47.	2004/12	Immunohistochemical localization of klotho protein in brain, kidney, and reproductive organs of mice
48.	2004/10	Analysis of retrograde ejaculation using color Doppler ultrasonography before and after transurethral collagen injection
49.	2004/08	Ureteroscopy using a detachable access sheath
50.	2004/06	Aldosterone Regulation for 18 Years in a Case of Primary Aldosteronism.
51.	2004/06	High-energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia:Comparative study between 30-and 60-minute single treatments
52.	2004/05	Comparative study of ureteral stripping versus open ureterectomy for nephroureterectomy in patients with transitional carcinoma of the renal pelvis
53.	2003/11	Hypothyroidism associated with anti-human chorionic gonadotropin antibodies secondarily produced by gonadotropin therapy in a case of idiopathic hypothalamic hypogonadism.
Display 5 items
Display all(53)

■ Presentations

1.	2019/11/09	Preventive effect of tadalafil for chronic inflammation in the prostate （Speech，General）
2.	2019/10/19	Renal Cell Carcinoma in Japanese Patients with End-Stage Renal Disease （Poster notice，General）
3.	2019/10/19	Validation of the Prostate Imaging and Reporting Data System Version 2(PI-RADS v2) for the detection of prostate cancer in Japanese men with elevated PSA Level. （Poster notice，General）
4.	2019/10	Anti-inflammatory Effects of lndoleamine 2,3-dioxygenase Inhibition in the Male Genital Inflammation （Poster notice，General）
5.	2019/05/05	Therapeutic effect of tadalafil in the chronic prostatitis （Poster notice，General）
6.	2019/04/11	The application of color Doppler ultrasonography in patients with ejaculation dysfunction and a male volunteer with the squirting phenomenon after ejaculation: an update （Poster notice，General）
7.	2019/03/17	Therapeutic effect of tadalafil in the chronic prostatitis （Poster notice，General）
8.	2018/09/23	Laparoscopic adrenal-sparing surgery in pheochromocytoma associated with multiple endocrine neoplasia type 2A （Speech，General）
9.	2018/09/20	Therapeutic effect of indoleamine 2,3-dioxygenase (IDO) inhibitor in the male genital inflammation （Speech）
10.	2018/09/19	Therapeutic effect of indoleamine 2,3-dioxygenase (IDO) inhibitor in the male genital inflammation （Poster notice）
11.	2018/09/19	Therapeutic effect of indoleamine 2,3-dioxygenase (IDO) inhibitor in the male genital inflammation （Speech，General）
12.	2018/05/18	Risk of secondary bladder cancer after high dose rate brachytherapy for prostate cancer （Speech，General）
13.	2018/04/19	The role of indoleamine 2,3-dioxygenase (IDO) in prostatitis （Speech，General）
14.	2018/03/17	Therapeutic effect of indoleamine 2,3-dioxygenase inhibitor in epididymitis （Speech，General）
15.	2017/10/19	Prospective study of a switching GnRH agonist therapy in castration resistant prostate cancer in Japanese patients （Poster notice，General）
16.	2017/05/12	Therapeutic effect of indoleamine 2,3-dioxygenase inhibitor in epididymitis （Speech，General）
17.	2017/05/12	Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion （Speech，General）
18.	2017/05/12	Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion （Poster notice，General）
19.	2017/03/24	Therapeutic effect of indoleamine 2,3-dioxygenase inhibitor in epididymitis （Poster notice，General）
20.	2017/03/24	Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion （Speech，General）
21.	2017/01/14	Effects of hydrogen-rich water in a bladder output obstruction (BOO) model （Poster notice，General）
22.	2017/01/14	Effects of microscopic subinguinal varicocelectomy on semen analysis findings and fertility of infertile male patients with varicocele （Poster notice，General）
23.	2016/11/11	Endoscopic removal of Memotherm^R using holmium YAG laser:A report of 3 cases （Poster notice，General）
24.	2016/11/11	Initial experience with the EMARO pneumatic laparoscopic holder robot in laparoscopic urological surgery
25.	2016/11/11	Therapeutic results and complications of ureteroscopic lithotripsy （Poster notice，General）
26.	2016/05/07	Tadalafil for male LUTS improves endothelial function （Speech，General）
27.	2016/05/07	The role of indoleamine 2,3-dioxygenase in epididymitis （Speech，General）
28.	2016/04/23	The Role of Alpha-blockers on Sexual Function （Speech，Panelist at Symposium/Workshop (Appointed)）
29.	2016/04/02	Effects of microscopic subinguinal varicocelectomy on semen analysis findings and fertility of infertile male patients with varicocele （Speech，General）
30.	2016/04/02	Maintenance of Male Sexual Function is Important for Anti-Aging （Speech，Panelist at Symposium/Workshop (Other)）
31.	2016/04/01	Pilot study of penile brachial index for Erectile Dysfunction （Speech，General）
32.	2016/03/12	The role of indoleamine 2,3-dioxygenase in epididymitis （Speech，General）
33.	2015/05/17	Non invasive velocity-flow video urodynamics using Doppler ultrasonography detection of periodic detrusor arrest during micturition in underactive bladder syndrome （Speech，General）
34.	2015/05/15	3D-ultrasound oriented adjustment for sphincteric urethra prior to velocity-flow evaluation using Doppler ultrasonography （Poster notice，General）
35.	2015/04/19	The Role of Alpha-blockers on Sexual Function （Speech）
36.	2015/02	Evaluation of vascular endothelial function for patients with Erectile Dysfunction （Poster notice，General）
37.	2015/02	Maintenance of oral administration of anticholinergic drugs for overactive bladder （Poster notice，General）
38.	2014/10/23	Change of sexual functions in patients with benign prostatic hyperplasia after holmium laser enucleation of the prostate (HoLEP). （Speech）
39.	2014/09/04	Unilateral adrenalectomy followed by contralateral laparoscopic partial adrenalectomy for men 2a: A report of two cases （Speech，General）
40.	2014/07/21	Characterization of Sterol-Activated Signalling Pathways in Sertoli Cells （Speech，General）
41.	2013/11/07	The relationships between salivary testosterone, serum sex hormones and lower urinary tract symptoms, sexual function in patients with benign prostate hyperplasia. （Speech，General）
42.	2013/11/07	Use of PDE5 inhibitors in elderly at Kawasaki medical school. （Speech，General）
43.	2013/10/24	A peritoneal wall anchor technique using a new device for laparoscopy-assisted catheter placement in peritoneal dialysis （Speech，General）
44.	2013/09/11	Spectrum of renal cell carcinoma histological subtypes arising end-stage renal disease. （Poster notice，General）
45.	2013/09/09	Change of Urinary, Sexual, and Bowel Function after Holmium Laser Enucleation of the Prostate (HoLEP) for Benign Prostatic Hyperplasia. （Poster notice，General）
46.	2013/09/09	The Relationships between Salivary Testosterone, Serum Sex Hormones and Lower Urinary Tract Symptoms, Sexual Function in Patients with Benign Prostate Hyperplasia. （Poster notice，General）
47.	2013/06/01	Experience in the treatment of Peyronie's disease/phallocampsis （Poster notice，General）
48.	2013/05/31	Correlation between lower urinary tract symptoms and sexual function after alpha-1 blockers in men with benign prostatic hyperplasia （Speech，Panelist at Symposium/Workshop (Other)）
49.	2013/05/07	Correlation of urinary oxidant stress marker level with the response of antimuscarinic therapy in patients with female overactive bladder （Speech，General）
50.	2013/04/25	Silodosin: Its Potential for Treating Various Urological Conditions （Speech）
51.	2013/03/16	Vasohibin-1 is a novel independent predictor of disease-free survival in curatively operated renal cell carcinoma patients （Poster notice，General）
52.	2013/02/14	Change of sexual functions in patients with benign prostatic hyperplasia after holmium laser enucleation of the prostate (HoLEP) （Poster notice，General）
53.	2013/02/14	Comparison of transperineal and transrectal 12-core initial prostate biopsy with PSA levels between 4.0 and 20.0 ng/ml （Speech，General）
54.	2013/02/14	Correlation with urothelium and primary symptoms in interstitial cystitis: investigation of scanning electron microscopy （Poster notice，General）
55.	2013/02/14	Investigation of histological feature and bladder function in rat insterstitial cystitis model （Poster notice，General）
56.	2012/12/14	Analysis of ejaculation （Speech，Panelist at Symposium/Workshop (Other)）
57.	2012/10/01	Long-Term Compliance and Treatment Failure of alpha1-Blocker for Patients with Male Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia. （Poster notice，General）
58.	2012/09/07	Incidental Prostate Cancer in Holmium Laser Enucleation of the Prostate (HoLEP) （Poster notice，General）
59.	2012/09/05	Prognostic factors in subsequent development of bladder cancer after the surgical management of primary upper urinary tract urothelial carcinoma （Poster notice，General）
60.	2012/08/04	Analysis of human ejaculation using color Doppler ultrasonography （Speech，Panelist at Symposium/Workshop (Other)）
61.	2012/08/04	Evaluation of patients with symptoms of male andropause （Poster notice，General）
62.	2012/05/22	Improvement of sexual function in patients with benign prostatic hyperplasia treated by holmium laser enucleation of the prostate (HoLEP) （Speech，General）
63.	2012/05/21	Clinical efficacy of a new botulinum toxin type A free of complexing proteins in the treatment of refractory neurogenic and idiopathic detrusor overactivity （Poster notice，General）
64.	2012/05/21	Correlation with urinary epithelium and primary symptoms in interstitial cystitis: investigation of scanning electron microscopy （Speech，General）
65.	2012/04/23	Improvement of sexual function in patients with benign prostatic hyperplasia treated by holmium laser enucleation of the prostate (HoLEP) （Speech，General）
66.	2012/02/04	Use of Fuhrman grading system for Japanese patients with renal cell carcinoma （Poster notice，General）
67.	2011/10/29	Forty percent of patients with ureteral stones who visit the emergency room first are not followed by urologists. （Speech，General）
68.	2011/10/29	Health-Related Quality of Life in Patients with Localized Prostate Cancer Received High-Dose-Rate Brachytherapy: A Time-Course Analysis. （Speech）
69.	2011/10/29	Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after initial treatment. （Speech，General）
70.	2011/10/19	Comparison of Two Different Antimuscarinics, Imidafenacin and Solifenacin for Treatment of Overactive Bladder: A Prospective Randomized Controlled Study （Poster notice，General）
71.	2011/10/19	Correlation of Urinary Nerve Growth Factor Level With the Response of Antimuscarinic Therapy in Patients With Overactive Bladder （Poster notice，General）
72.	2011/10/18	Correlation with Urinary Epithelium and Primary Symptoms in Interstitial Cystitis: Inbestigation of Scannin Electron Microscopy （Poster notice，General）
73.	2011/10/18	Risk Factor Analysis of Patients’Dissatisfaction After Holmium LaserEnucleation of the Prostate (HoLEP)for Benign Prostatic Hyperplasia （Poster notice，General）
74.	2011/10/17	Efficacy of Transperineal Versus Transrectal 12-Core Initial Prostate Biopsy with PSA Levels Between 4.0 and 20.0 ng/ml （Speech，General）
75.	2011/10/17	Prognostic Factors and Survival of Renal Cell Carcinoma in Japanese Patients （Poster notice，General）
76.	2011/10/17	Retroperitoneal Dedifferentiated Liposarcoma with Production of Granulocyte Colony-Stimulating Factor (G-CSF) Accompanied by Spontaneous Rupture: PET/CT Imaging of a G-CSF-Producting Tumor （Poster notice，General）
77.	2011/09/01	Comparison of two different antimuscarinics, Imidafenacine and solifenacin, for treatment of overactive bladder: A prospective randomized controlled study （Poster notice，General）
78.	2011/08/31	Correlation of urinary nerve growth factor level with the response of antimuscarinic therapy in patients with overactive bladder （Poster notice，General）
79.	2011/08/31	Correlation with urinary epithelium and primary symptoms in interstitial cystitis: investigation of scanning electron microscopy （Poster notice，General）
80.	2010/08/13	Science of Ejaculation- SILODOSIN changes the world
81.	2010/07/09	Function of Prostate in Ejaculation （Speech，Panelist at Symposium/Workshop (Other)）
82.	2009/11/03	Does transection of the spermatic cord lower the incidence of inguinal hernia after radical retropubic prostatectomy? （Poster notice，General）
83.	2009/11/01	The Effects of 3 Types of Alpha1-Adrenoceptor Blockers on Lower Urinary Tract Symptoms and Sexual Functions in Men with Benign Prostatic Hyperplasia
84.	2009/10/15	HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH LOCALIZED PROSTATE CANCER RECEIVED HIGH-DOSE-RATE BRACHYTHERAPY: A TIME-COUSE ANALYSIS （Speech，Panelist at Symposium/Workshop (Other)）
85.	2009/10/15	THE PROSTATE AS EJACULATION DEVICE IN HEALTHY MALE AND BENIGN PROSTATIC HYPERPLASIA IN THE AGING MALE （Speech）
86.	2008/09/20	Clinical outcome in patients with locally and locally advanced prostate cancer treated with high-dose-rate brachytherapy. （Speech，General）
87.	2008/09/20	Optimal approach for prostate cancer detection as initial biopsy:A prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. （Speech，General）
88.	2007/11/17	IRIDIUM-192 HIGH-DOSE-RATE BRACHYTHERAPY FOR T1c-T3bN0M0 PROSTATE CANCER （Speech）
89.	2007/09/02	IRIDIUM-192 HIGH-DOSE-RATE BRACHYTHERAPY FOR T1c-T3bN0M0 PROSTATE CANCER （Speech，General）
90.	2007/09	Health-related Quality of Life in Patients with Localized Prostate Cancer Received High-Dose-Rate Brachytherapy: A Time-Course Analysis （Poster notice，General）
91.	2007/05/19	Correlation　of urinary nerve growth factor level with pathogenesis of overactive bladder （Poster notice）
92.	2007/05/19	Ejaculatory dysfunction caused by new A1-blocker: analysis of human ejaculatory phenomenon using color doppler ultrasonography （Speech）
93.	2006/09/15	The experience of using dual lumen ureteral access sheath (AquaGuideTM) in ureteropyeloscopy （General）
Display 5 items
Display all(93)